Qing‐Ling Fu

8.7k total citations · 2 hit papers
92 papers, 3.7k citations indexed

About

Qing‐Ling Fu is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Qing‐Ling Fu has authored 92 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 25 papers in Genetics and 25 papers in Immunology. Recurrent topics in Qing‐Ling Fu's work include Mesenchymal stem cell research (23 papers), Extracellular vesicles in disease (20 papers) and IL-33, ST2, and ILC Pathways (20 papers). Qing‐Ling Fu is often cited by papers focused on Mesenchymal stem cell research (23 papers), Extracellular vesicles in disease (20 papers) and IL-33, ST2, and ILC Pathways (20 papers). Qing‐Ling Fu collaborates with scholars based in China, Hong Kong and United States. Qing‐Ling Fu's co-authors include Xingliang Fan, Yuelin Zhang, Xin Li, Weiping Wen, Geng Xu, Qizhou Lian, Yueqi Sun, Shu‐Bin Fang, Jianbo Shi and Jianbo Shi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Qing‐Ling Fu

88 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy

2020 381 citations Xingliang Fan, Yuelin Zhang et al. Cellular and Molecular Life Sciences profile →
Epidemiology of chronic rhinosinusitis: results from a cross‐sectional survey in seven Chinese cities

2015 312 citations Jianbo Shi, Qing‐Ling Fu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qing‐Ling Fu China	33	1.5k	1.2k	901	713	591	92	3.7k
Slobodan Vukičević Croatia	51	4.0k 2.6×	1.1k 0.9×	1.7k 1.9×	405 0.6×	473 0.8×	181	9.2k
Tadaaki Kirita Japan	40	1.8k 1.2×	317 0.3×	1.4k 1.6×	328 0.5×	276 0.5×	352	5.7k
Nyall R. London United States	24	947 0.6×	152 0.1×	787 0.9×	302 0.4×	234 0.4×	141	3.1k
Jim Middleton United Kingdom	25	1.2k 0.8×	1.7k 1.4×	952 1.1×	826 1.2×	198 0.3×	36	4.1k
Daniel J. Ceradini United States	22	1.3k 0.9×	766 0.7×	1.3k 1.4×	520 0.7×	146 0.2×	58	3.7k
Mei Wan United States	45	3.8k 2.5×	698 0.6×	727 0.8×	641 0.9×	597 1.0×	127	6.9k
Hitoshi Okochi Japan	36	3.1k 2.0×	1.1k 0.9×	1.2k 1.4×	942 1.3×	266 0.5×	108	6.3k
Ling Qin United States	39	2.1k 1.4×	390 0.3×	601 0.7×	293 0.4×	242 0.4×	131	4.5k
Jianan Wang China	33	1.0k 0.7×	984 0.9×	1.4k 1.5×	610 0.9×	430 0.7×	150	4.0k
Luc Sensebé France	45	2.6k 1.7×	5.3k 4.6×	2.9k 3.2×	762 1.1×	547 0.9×	131	8.7k

Countries citing papers authored by Qing‐Ling Fu

Since Specialization

Citations

This map shows the geographic impact of Qing‐Ling Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing‐Ling Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing‐Ling Fu more than expected).

Fields of papers citing papers by Qing‐Ling Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing‐Ling Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing‐Ling Fu. The network helps show where Qing‐Ling Fu may publish in the future.

Co-authorship network of co-authors of Qing‐Ling Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Qing‐Ling Fu. A scholar is included among the top collaborators of Qing‐Ling Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing‐Ling Fu. Qing‐Ling Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fang, Shu‐Bin, Xiaoqing Liu, Bi‐Xin He, et al.. (2024). Plasma extracellular vesicles regulate the Functions of Th2 and ILC2 cells via miRNA-150-5p in patients with allergic rhinitis. International Immunopharmacology. 144. 113644–113644.

He, Bi‐Xin, Zicong Wu, Xiaoqing Liu, et al.. (2024). Small extracellular vesicles derived from human mesenchymal stem cells prevent Th17-dominant neutrophilic airway inflammation via immunoregulation on Th17 cells. International Immunopharmacology. 133. 112126–112126. 2 indexed citations

Deng, Xiaohui, et al.. (2024). Increased circulating LOX-1+ neutrophils activate T cells and demonstrate a pro-inflammatory role in allergic rhinitis. Heliyon. 10(17). e36218–e36218. 4 indexed citations

Xu, Zhanxue, Qing‐Ling Fu, Chao He, et al.. (2023). Dual‐Targeting Nanovesicles Carrying CSF1/CD47 Identified from Single‐Cell Transcriptomics of Innate Immune Cells in Heart Transplant for Alleviating Acute Rejection. Advanced Healthcare Materials. 13(7). e2302443–e2302443. 4 indexed citations

Li, Qing, Bo Li, Wenrong Xu, et al.. (2023). Requirements for human mesenchymal stem cell‐derived small extracellular vesicles. SHILAP Revista de lepidopterología. 1(1). 26 indexed citations

Li, Qing, Bo Li, Wenrong Xu, et al.. (2023). Requirements for human pluripotent stem cell derived small extracellular vesicles. SHILAP Revista de lepidopterología. 1(2). 9 indexed citations

Peng, Yaqi, et al.. (2023). Mesenchymal stromal cells and their small extracellular vesicles in allergic diseases: From immunomodulation to therapy. European Journal of Immunology. 53(10). e2149510–e2149510. 9 indexed citations

Liu, Xiaoqing, Yaqi Peng, Dehua Chen, et al.. (2023). Dendritic cells mediated by small extracellular vesicles derived from MSCs attenuated the ILC2 activity via PGE2 in patients with allergic rhinitis. Stem Cell Research & Therapy. 14(1). 180–180. 13 indexed citations

Liu, Xiaoqing, Bi‐Xin He, Zicong Wu, et al.. (2023). Mesenchymal stem cells overexpressing interleukin-10 prevent allergic airway inflammation. Stem Cell Research & Therapy. 14(1). 369–369. 11 indexed citations

10.

Peng, Yaqi, Zhibin Xu, Shu‐Bin Fang, et al.. (2022). Mesenchymal stromal cells‐derived small extracellular vesicles modulate DC function to suppress Th2 responses via IL‐10 in patients with allergic rhinitis. European Journal of Immunology. 52(7). 1129–1140. 32 indexed citations

11.

Fan, Xingliang, Zhibin Xu, Chenglin Li, et al.. (2021). Mesenchymal Stem Cells Regulate Type 2 Innate Lymphoid Cells via Regulatory T Cells through ICOS-ICOSL Interaction. Stem Cells. 39(7). 975–987. 18 indexed citations

12.

Fan, Xingliang, Yuelin Zhang, Xin Li, & Qing‐Ling Fu. (2020). Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cellular and Molecular Life Sciences. 77(14). 2771–2794. 381 indexed citations breakdown →

13.

Fang, Shu‐Bin, Hongyu Zhang, Cong Wang, et al.. (2020). Small extracellular vesicles derived from human mesenchymal stromal cells prevent group 2 innate lymphoid cell‐dominant allergic airway inflammation through delivery of miR‐146a‐5p. Journal of Extracellular Vesicles. 9(1). 1723260–1723260. 175 indexed citations

14.

Fang, Shu‐Bin, Hongyu Zhang, Cong Wang, et al.. (2020). Small extracellular vesicles derived from human MSCs prevent allergic airway inflammation via immunomodulation on pulmonary macrophages. Cell Death and Disease. 11(6). 409–409. 50 indexed citations

15.

Fan, Xingliang, et al.. (2019). Mesenchymal stem cells for inflammatory airway disorders: promises and challenges. Bioscience Reports. 39(1). 32 indexed citations

16.

Li, Chenglin, Zhibin Xu, Xingliang Fan, et al.. (2018). MicroRNA-21 Mediates the Protective Effects of Mesenchymal Stem Cells Derived from iPSCs to Human Bronchial Epithelial Cell Injury Under Hypoxia. Cell Transplantation. 27(3). 571–583. 13 indexed citations

17.

Fang, Shu‐Bin, Hongyu Zhang, Xingliang Fan, et al.. (2018). Human iPSC-MSCs prevent steroid-resistant neutrophilic airway inflammation via modulating Th17 phenotypes. Stem Cell Research & Therapy. 9(1). 147–147. 30 indexed citations

18.

Fan, Xingliang, Xin Li, Chenglin Li, et al.. (2018). Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-κB in allergic rhinitis patients. Stem Cell Research & Therapy. 9(1). 170–170. 34 indexed citations

19.

Li, Chenglin, Yun Leng, Bin Zhao, et al.. (2017). Human iPSC-MSC-Derived Xenografts Modulate Immune Responses by Inhibiting the Cleavage of Caspases. Stem Cells. 35(7). 1719–1732. 38 indexed citations

20.

Fu, Qing‐Ling, et al.. (2016). IgG4-Related Disease Mimicking Nasal Malignant Carcinoma with Multiple Organ Metastases: A Case Report. 1(1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact